Have been diamond on @delta for years but increasingly frusterated with them. Any suggestions for another airline/loyalty program to join? I mostly fly from dtw - often for work in us but also to eu or occasionally south america or middle east. Anybody suggestions?
🚨 BIG NEWS 🚨
Please welcome @DanCimini1 as our new Director of Program Development for the 2025/26 season!
🧢 6x State Champ
🏆 2024 D1 Coach of the Year
💯 548 career wins
One of the best minds in Michigan baseball is now PRIME.
#EverythingCounts#PrimeOnTop
My wife, daughter, and I stayed at an @Airbnb in NYC in November. Perfectly normal stay. Nothing happened. When we left, the owner said there was a small stain on the hardwood floor he couldn't clean and said it took him $7500 to fix, including literally replacing floorboards. We know nothing about this, saw nothing, looks totally unfamiliar. Feels like insurance fraud, or something? AirBNB took his side because we couldn't provide a picture of the floor at the exact minute we walked out the door. Are you kidding me? Has anyone else had an experience with AirBNB like this? Any attorneys who know how to deal with this sort of absurd claim?
Cappellini MD, et al. ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia #ASH24
Join us at SCDAA’s 52nd Annual National Convention on Oct. 23-26 for our Charles F. Whitten, M.D., Memorial Lecture. This special discussion will be presented by Wally Smith, M.D., a leading expert in sickle cell care with over 40 years of experience.
Timmerman Traverse for Sickle Forward hit the $1M goal for newborn screening and treatment! Heading to Kilimanjaro Sept. 10-17. Listen to Ted Love and Alan Anderson discuss on The Long Run. #sicklecellmatters
https://t.co/yPwjT2LCk6
We're thrilled to share the FDA has approved vorasidenib, representing a significant step forward for patients. Congrats to @ServierPharma and the Agios team for their early discovery and development efforts. Read more: https://t.co/4IH1n2cAsZ
Proud of this study and the data it provides for peds hemophilia A patients as we strive for optimal health ❤️💉🩸
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A | New England Journal of Medicine https://t.co/lkxXRpOYaU
Today is World Sickle Cell Awareness Day! We're proud to help raise awareness for #SickleCellDisease. Check out our roundtable interview with Dr. Wanda Whitten-Shurney, Teonna Woolford, and CEO Patrick Hines: https://t.co/iTNiWv3zYk
Today is World Sickle Cell Awareness Day. While SCD is curable, access to cure is limited to only a few. To transform SCD care, hydroxyurea, an effective disease modifying treatment, should be accessible to all patients regardless of where they live. @GlobalSCDN@SickKidsGlobal
We're pleased to announce the global Ph. 3 ENERGIZE-T study in adults with transfusion-dependent alpha- or beta-#thalassemia achieved its primary endpoint of transfusion reduction response with potential to become a novel advancement in care for patients. https://t.co/9qQ8hRXz1U